GlaxoSmithKline Cuts Full-Year Outlook as Weak Advair Sales Weigh - Presented by: The Aol. On Network

Shares of GlaxoSmithKline are falling on Wednesday after the drug-maker cut its full-year earnings outlook. In a statement, Glaxo said full-year sales are unlikely to increase, while earnings per share will be similar to last year.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
RAD $ 6.78 0.72 ▲ 11.88%
BAC $ 17.53 0.27 ▲ 1.56%
PBR $ 6.90 0.20 ▲ 2.99%
AAPL $ 112.65 3.24 ▲ 2.96%
TLM $ 7.78 0.14 ▲ 1.83%
GE $ 25.14 0.71 ▲ 2.91%
ORCL $ 45.35 4.19 ▲ 10.18%
PBR/A $ 7.17 0.15 ▲ 2.14%

As of 12/18/2014, 04:15 PM
More Most Active